ENHANCED SUBENDOCARDIAL PERFUSION DISTAL TO A FLOW-LIMITING CORONARY-ARTERY STENOSIS IN DOGS - COMPARATIVE EFFECTS OF NICORANDIL, A POTENTIAL NEW ANTIANGINAL AGENT, AND NITROGLYCERIN

被引:13
作者
GROSS, GJ
WARLTIER, DC
HARDMAN, HF
LAMPING, KA
机构
关键词
D O I
10.1097/00005344-198509000-00026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:977 / 982
页数:6
相关论文
共 14 条
[1]   EFFECTS OF NITROGLYCERIN ON TRANSMURAL MYOCARDIAL BLOOD-FLOW IN UNANESTHETIZED DOG [J].
BACHE, RJ ;
BALL, RM ;
COBB, FR ;
REMBERT, JC ;
GREENFIELD, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (06) :1219-1228
[2]   EFFECT OF NITROGLYCERIN AND NIFEDIPINE ON SUB-ENDOCARDIAL PERFUSION IN THE PRESENCE OF A FLOW-LIMITING CORONARY STENOSIS IN THE AWAKE DOG [J].
BACHE, RJ ;
TOCKMAN, BA .
CIRCULATION RESEARCH, 1982, 50 (05) :678-687
[3]  
BACHE RJ, 1982, CIRCULATION S1, V65, P19
[4]  
GROSS GJ, 1984, J PHARMACOL EXP THER, V228, P531
[5]   EVOLUTION OF REGIONAL ISCHEMIA DISTAL TO A PROXIMAL CORONARY STENOSIS - SELF-PROPAGATION OF ISCHEMIA [J].
GUYTON, RA ;
MCCLENATHAN, JH ;
MICHAELIS, LL .
AMERICAN JOURNAL OF CARDIOLOGY, 1977, 40 (03) :381-392
[6]   TECHNIQUE FOR PRECISE, GRADED ARTERIAL-STENOSIS AND OCCLUSION [J].
HOSKO, MJ ;
GROSS, GJ ;
WARLTIER, DC .
BASIC RESEARCH IN CARDIOLOGY, 1977, 72 (06) :651-659
[7]   EFFECTS OF NICORANDIL AND NIFEDIPINE ON PROTECTION OF ISCHEMIC MYOCARDIUM [J].
LAMPING, KA ;
CHRISTENSEN, CW ;
PELC, LR ;
WARLTIER, DC ;
GROSS, GJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (03) :536-542
[8]   COMPARATIVE EFFECTS OF A NEW NICOTINAMIDE NITRATE DERIVATIVE, NICORANDIL (SG 75), WITH NIFEDIPINE AND NITROGLYCERIN ON TRUE COLLATERAL BLOOD-FLOW FOLLOWING AN ACUTE CORONARY-OCCLUSION IN DOGS [J].
LAMPING, KA ;
GROSS, GJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (04) :601-608
[9]  
LAMPING KA, 1984, J PHARMACOL EXP THER, V229, P359
[10]   CARDIOVASCULAR EFFECTS OF A NEW CORONARY VASODILATOR N-(2-HYDROXYETHYL)NICOTINAMIDE NITRATE (SG-75) - COMPARISON WITH NITROGLYCERIN AND DILTIAZEM [J].
SAKAI, K ;
SHIRAKI, Y ;
NABATA, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (01) :139-150